Through relentless research and cutting-edge solutions, Fluent is reimagining diabetes management to empower people with diabetes — and the parents supporting them — to live fully and freely.
We are reimagining diabetes management to empower people with diabetes — and the parents supporting them — to live fully and freely. Through relentless research and cutting-edge solutions, we aim to achieve Zero Time Out of Range — shaping a future free from diabetes complications, fighting stigmatization, and breaking economic barriers.
Scientific rigor from the field of Formula 1 engineering applied to personalised blood glucose prediction models.
Fluent PrevYOU brings real-time personalised blood glucose predictions directly to your mobile device.
Dedicated solutions for parents of diabetic children and teens, with their caregivers.
To lead the future of pediatric diabetes care, where every child can thrive without limitations and live life on equal footing with their peers — today and tomorrow.
The personal journey that sparked the Fluent research project.
"Diabetes was one of those words I had always heard casually before meeting my wife. I learned to understand and comprehend what it means to deal with this disease through her experience, which is much more difficult to accept and face than if it were my own."
"However, I also received a great lesson: perhaps not all challenges will be won, but with intelligence and commitment, it is possible to manage diabetes well and take care of oneself."
Not long after, the idea for a research project for simpler and more effective management named Fluent was born.
Giuseppe has always been involved in research and development in a very different domain — Formula 1, Formula 2, and other automotive competitions. In this domain, he has had the privilege of helping shape the frontier of advanced technology. Beyond the breakthroughs, he has embraced a culture of innovation that sparks solutions with real competitive impact.
He believes this same spirit of innovation has inspired and keeps driving the work of all people contributing to the Fluent project.
Explore the global data: 589 million adults living with diabetes in 2024, projected to reach 852 million by 2050.
Learn how Fluent's research approach centers on individualized care for better outcomes.
Global epidemiological data from the IDF Diabetes Atlas 11th Edition (2024–2050).
Adults with diabetes globally in 2024 — representing 11.1% of all adults aged 20–79.
Projected number of adults living with diabetes by 2050 — a 45% increase in just 25 years.
While global population grows ~25%, diabetes prevalence is expected to grow nearly twice as fast.
Beyond the immediate management challenges, diabetes carries significant long-term complications when inadequately managed. These include cardiovascular disease, neuropathy, nephropathy, and retinopathy — reinforcing the urgent need for innovative management solutions like Fluent PrevYOU.
Source
International Diabetes Atlas — IDF 2025
Why a personalised approach is essential to achieving Zero Time Out of Range.
Fluent research project arises from the increasing prevalence of diabetes, both Type 1 and Type 2, and the need for personalised medicine approaches to enhance diabetes management and patient outcomes.
When it comes to children and adolescents, a truly personalised approach must extend beyond the individual. It must also engage and empower key figures in their lives — such as family members, teachers, and sports coaches — so they can actively contribute to achieving the goal while also easing the daily burden of diabetes management.
Every person's blood glucose response is unique. Our prediction model continuously adapts to the evolving biometric patterns of each user.
For young users, the care ecosystem includes parents, teachers, and sports coaches — all empowered with real-time guidance.
The ultimate goal: enabling every person with diabetes to maintain optimal blood glucose levels consistently.
Personalised blood glucose prediction is the key that shifts management from responding to events — to anticipating them.
It didn't take long to realise that making blood glucose predictions readily accessible to people was equally important. A prediction based on data that is hard to retrieve and/or provide to the algorithm wouldn't be very helpful for daily diabetes management. Therefore, Fluent ventured into the mobile-health space — equipping the prediction algorithm with the immediacy required for effective daily use.
The result of this journey is a mobile app called Fluent PrevYOU capable of delivering real-time personalised blood glucose predictions.
Understanding the difference between reactive and proactive diabetes management.
Fluent PrevYOU is a personalised solution for diabetes control — from real-time therapy management to blood glucose prediction.
Fluent PrevYOU empowers people with diabetes — and the parents supporting diabetic children — with the world's most advanced management solution, developed to take on the "Zero Time Out of Range" challenge.
Feel confident that your child is safe when you're not physically present — at school, at a friend's house.
Help them feel normal among their peers, rather than singled out by their condition.
Avoid feeling anxious about your glucose dropping during exercise, driving, or sleep.
Be seen as someone who can fully take part in sports, travel, and social occasions.
Terms of Use for the Fluent PrevYOU Mobile Application
Current version available on Google Play: the version of Fluent PrevYOU currently published on Google Play is a demonstration (“demo”) version. Its sole purpose is to showcase the App's planned functionalities and let users familiarise themselves with its interface and workflow. The blood glucose prediction, “In Range ++”, and Digital Therapy management features are disabled in the publicly distributed version and produce no output of any kind — no prediction, suggestion, reminder, or other information generated by these features can be obtained through it. These features are made available, in fully functional form, exclusively to participants enrolled in an early access program (see Section 4.3). See Section 3.1 for further detail.
Fluent PrevYOU deals with health-related information and supports the daily management of diabetes. Before using the App, please read these Terms and Conditions in full, together with the Clinical and Digital-Therapy Disclaimer (Section 6) and the Limitation of Liability (Section 8). The App does not replace professional medical advice, diagnosis, or treatment, and must always be used alongside the guidance of a qualified healthcare provider.
These Terms and Conditions (the “Terms”) constitute a legally binding agreement between you (“you”, “your”, or the “User”) and CTC, governing your access to and use of the Fluent PrevYOU mobile application and any associated services, content, and features.
By downloading, installing, accessing, registering for, or otherwise using the App, you confirm that you have read, understood, and agree to be bound by these Terms and by our Privacy Policy. If you do not agree with any part of these Terms, you must not download, access, or use the App.
If you are accessing or using the App on behalf of a child or another individual (see Section 5, “Use by Parents and Guardians on Behalf of Minors”), your acceptance of these Terms is given both on your own behalf and, where applicable, on behalf of that individual.
For the purposes of these Terms, the following definitions apply:
The version of the App currently distributed to the general public via Google Play has the sole purpose of demonstrating the App's planned functionalities and allowing users to familiarise themselves with its interface, navigation, and general workflow.
In this publicly distributed version: the blood glucose prediction feature, the “In Range ++” feature, and the Digital Therapy management features are disabled. These features do not process real biometric data and do not produce or display any prediction, suggestion, output, reminder, or other information of any kind. No data, figure, or piece of information generated by these features can be obtained through the publicly distributed demo version, whether real, illustrative, or simulated. Any screen relating to these features within the demo version is provided solely to showcase the App's planned navigation and interface, contains no functional output whatsoever, and must not be relied upon for any purpose, including any decision relating to insulin dosage, diet, physical activity, or any other aspect of diabetes management.
We may, at our discretion and without prior notice, change which features are demonstrative versus operative in any given release of the publicly distributed App, including as part of a phased rollout of functionality previously reserved to early access participants.
The fully operative blood glucose prediction, “In Range ++”, and Digital Therapy management features described elsewhere in these Terms and on our website are made available exclusively to individuals enrolled in an early access program (see Section 4.3), under any additional terms communicated at the time of enrolment. If you have not been enrolled in an early access program, you should assume that these features are not operative for you, regardless of how they may appear or be described within the App or on our website.
Subject to the above, Fluent PrevYOU is designed to support the daily management of Type 1 and Type 2 diabetes through:
The App is currently made available free of charge on Android via Google Play. We reserve the right to modify, suspend, or discontinue any feature of the Service, in whole or in part, at any time, including features currently offered through early access programs, subject to Section 12 (Changes to These Terms and to the Service).
At present, artificial intelligence technology is not used in the blood glucose prediction model. Should this change in the future, we will update these Terms and the accompanying documentation accordingly.
The App is intended for use by: (a) adults (18 years of age or older) living with diabetes; (b) parents or legal guardians managing the diabetes care of a child or teenager aged 0–18, as described in Section 5; and (c) healthcare providers and members of an authorised Care Network supporting such individuals.
The App is not intended to be used directly and unsupervised by children or teenagers under the age of 18. Any use of the App by or on behalf of a minor must be initiated, configured, and supervised by a parent or legal guardian in accordance with Section 5.
To access certain features, you may be required to register an Account and provide accurate, current, and complete information. You are responsible for maintaining the confidentiality of your login credentials and for all activity that occurs under your Account. You must notify us promptly at support@fluentcommunity.com of any unauthorised use of your Account.
As explained in Section 3.1 and 3.2, the fully operative blood glucose prediction, “In Range ++”, and Digital Therapy management features (including “PrevYOU for Parents”) are only made available through limited early access programs. Participation in an early access program is voluntary, may require submission of additional information (such as diabetes type and reference hospital/clinic), and may be subject to additional terms communicated to you at the time of enrolment. Features offered in early access are provided on an experimental, “as available” basis and may be modified, limited, or withdrawn at any time.
Fluent PrevYOU is designed, in part, to support parents and legal guardians of children and teenagers (aged 0–18) living with diabetes. Where the App is used in connection with a minor, the following provisions apply:
If you become aware that a minor is using the App directly and without appropriate parental or guardian supervision, please contact us immediately at support@fluentcommunity.com so that we can take appropriate action.
This Section applies both to the publicly distributed demo version and to any functional version of the App made available through an early access program. As set out in Section 3.1, the blood glucose prediction, “In Range ++”, and Digital Therapy features are not operative in the version currently available on Google Play; the disclaimers below become directly relevant once, and to the extent that, such features are activated for you through an early access program.
Fluent PrevYOU is an informational and self-management support tool. It is not intended to, and does not, provide medical diagnosis, medical advice, or treatment, and it is not a substitute for consultation with, or the professional judgment of, a qualified Healthcare Provider.
You should always consult your (or your child's) doctor, diabetologist, dietician, or other qualified Healthcare Provider before making any change to insulin dosage, medication, diet, or exercise routine, and before relying on any prediction, suggestion, reminder, or piece of information provided by the App. Never disregard, delay, or discontinue professional medical advice or treatment because of information obtained through the App.
The blood glucose prediction and “In Range ++” features generate estimates and suggestions based on mathematical/statistical models, the biometric information you provide, and patterns you select. These are probabilistic estimates, not clinical measurements or guarantees, and may be inaccurate, incomplete, or unsuitable for your specific physiological condition on a given day. They do not replace blood glucose measurement by a certified glucometer or continuous glucose monitor (CGM), nor any other diagnostic device.
The Digital Therapy management features allow a User or their Healthcare Provider to load therapy, diet, and physical activity plans into the App and to receive reminders and prompts based on those plans. These features are tools for organising and reinforcing adherence to a treatment plan that has already been prescribed by a Healthcare Provider. We do not review, validate, or endorse the clinical appropriateness of any therapy or diet plan entered into the App by a User, parent/guardian, or Healthcare Provider, and we are not responsible for errors in the plan as entered, or for its clinical suitability.
The App must never be used as a tool for managing medical emergencies. If you or someone in your care experiences symptoms of a severe hypoglycaemic or hyperglycaemic episode, diabetic ketoacidosis, loss of consciousness, or any other medical emergency, contact emergency services immediately (for example, 999 or 112) or seek immediate in-person medical attention. Do not rely on the App, its predictions, or its notifications in an emergency situation.
Unless expressly stated otherwise within the App or in accompanying documentation, Fluent PrevYOU is provided as a general wellness and self-management support tool. Any references to clinical trials, academic partnerships, or research collaborations (including those with the University of Verona and the University of Padova) describe the scientific research underpinning the App's development and do not constitute a representation that the App has been certified as a medical device in any jurisdiction, unless explicitly stated.
The App, including its source code, algorithms, prediction models, visual design, graphics, logos, trademarks (including “Fluent” and “Fluent PrevYOU”), text, and all other content and underlying technology (collectively, the “IP”), is owned by, or licensed to, CTC and is protected by copyright, trademark, database, trade secret, and other intellectual property laws and treaties.
Subject to your compliance with these Terms, we grant you a limited, non-exclusive, non-transferable, revocable licence to download and use the App on a personal device you own or control, solely for your own personal, non-commercial use (or, in the case of a parent/guardian, for the care of the minor(s) for whom you are responsible).
You must not: (a) copy, modify, reverse-engineer, decompile, or disassemble the App or any part of its underlying models or algorithms, except to the extent expressly permitted by applicable law; (b) rent, lease, sell, sublicense, assign, or otherwise transfer any right in the App; (c) remove, obscure, or alter any proprietary notices; or (d) use the Fluent name, logo, or trademarks without our prior written consent.
Any feedback, suggestions, or ideas you voluntarily submit to us regarding the App may be used by us without restriction or compensation to you.
Nothing in these Terms limits or excludes our liability for death or personal injury caused by our negligence, for fraud or fraudulent misrepresentation, or for any other liability that cannot be limited or excluded under applicable law.
Subject to the foregoing, and to the fullest extent permitted by applicable law:
You acknowledge that these limitations reflect a reasonable allocation of risk given that the App is offered free of charge as a self-management support tool, and that they are a fundamental basis of the agreement between you and us.
To the fullest extent permitted by applicable law, you agree to indemnify and hold harmless CTC, its officers, employees, contractors, and academic partners from and against any claims, liabilities, damages, losses, and expenses (including reasonable legal fees) arising out of or in any way connected with: (a) your breach of these Terms; (b) your misuse of the App; (c) any information or Content you (or a minor in your care) submit through the App; or (d) your violation of any applicable law or third-party right.
Our collection and use of personal data, including health-related data, is described in our Privacy Policy, available at https://www.iubenda.com/privacy-policy/35716840/full-legal (the “Privacy Policy”), which forms an integral part of these Terms. By using the App, you also agree to the terms of the Privacy Policy.
Health-related information you or a parent/guardian submit is treated as a special category of personal data. We implement appropriate technical and organisational measures to protect such data, in accordance with the UK General Data Protection Regulation (UK GDPR), the Data Protection Act 2018, and, where applicable, the EU GDPR.
You may request access to, correction of, or permanent deletion of your account and associated data at any time by contacting support@fluentcommunity.com. Upon verification of your identity, we will action such requests in accordance with applicable data protection law and our Privacy Policy.
When using the App, you agree that you will not:
We reserve the right to suspend or terminate your Account, without notice, if we reasonably believe you have violated these Terms or applicable law.
The App may integrate with, or provide links to, third-party services, including Google Play, email providers used for Care Network notifications, academic research platforms, and third-party payment processors used for voluntary donations. We do not control, and are not responsible for, the content, accuracy, availability, or privacy practices of such third-party services. Your use of any third-party service is governed by that third party's own terms and privacy policy.
We may update or modify these Terms from time to time to reflect changes in the Service, legal or regulatory requirements, or our business practices, including as the App evolves from early access features toward general availability.
Where changes are material, we will endeavour to provide reasonable advance notice, such as via an in-app notification, a notice on our website (www.fluentcommunity.com), or by email to the address associated with your Account. The “Last updated” date at the top of these Terms indicates when they were last revised.
Your continued use of the App after the effective date of any revised Terms constitutes your acceptance of those changes. If you do not agree to the revised Terms, you must stop using the App and may request deletion of your Account in accordance with Section 10.
We also reserve the right to modify, suspend, or discontinue the App, or any feature of it (including early access features), at any time and without liability to you, subject to applicable law.
These Terms remain in effect for as long as you use the App. You may stop using the App, and request deletion of your Account and associated data, at any time by contacting support@fluentcommunity.com.
We may suspend or terminate your access to the App, in whole or in part, at any time, with or without cause or notice, including where we reasonably believe you have violated these Terms, engaged in fraudulent or unlawful activity, or where continued provision of the Service to you would expose us or others to legal or safety risk.
Sections 6 (Clinical and Digital-Therapy Disclaimer), 7 (Intellectual Property), 8 (Limitation of Liability), 9 (Indemnification), and 15 (Governing Law and Jurisdiction), together with any other provision that by its nature should survive, will survive termination of these Terms.
These Terms, and any dispute or claim arising out of or in connection with them or their subject matter, formation, or validity (including non-contractual disputes or claims), shall be governed by and construed in accordance with the laws of England and Wales, without regard to its conflict-of-laws principles.
The courts of England and Wales shall have exclusive jurisdiction to settle any dispute or claim arising out of or in connection with these Terms, save that if you are a consumer resident in the European Union, you may also be entitled to bring proceedings in the courts of your country of residence, and mandatory consumer-protection provisions of that jurisdiction will continue to apply to the extent required by applicable law.
These Terms, together with the Privacy Policy and Cookie Policy, constitute the entire agreement between you and CTC regarding the App and supersede any prior agreements or understandings, whether written or oral.
If any provision of these Terms is found to be invalid, illegal, or unenforceable by a court of competent jurisdiction, that provision shall be deemed modified to the minimum extent necessary to make it valid and enforceable, and the remaining provisions shall continue in full force and effect.
Our failure to enforce any right or provision of these Terms shall not be deemed a waiver of such right or provision.
You may not assign or transfer these Terms, or any rights or obligations under them, without our prior written consent. We may assign these Terms, in whole or in part, without restriction, including in connection with a merger, acquisition, or sale of assets.
We shall not be liable for any failure or delay in performance resulting from causes beyond our reasonable control, including acts of God, natural disasters, war, terrorism, labour disputes, internet or telecommunications failures, or governmental action.
These Terms are made available in English. In the event of any conflict between the English version and a translation into another language, the English version shall prevail, unless otherwise required by mandatory local law.
Company: Callea Tech Center LTD
Registered office: 61 Earls Ct Square, London SW5 9DG, United Kingdom
If you have questions about these Terms, please contact us:
Condizioni d'Uso dell'Applicazione Mobile Fluent PrevYOU
Versione attualmente disponibile su Google Play: la versione di Fluent PrevYOU attualmente pubblicata su Google Play è una versione demo. Il suo unico scopo è mostrare le funzionalità previste dell'App e permettere agli utenti di familiarizzare con la sua interfaccia e il suo funzionamento generale. Le funzionalità di predizione glicemica, “In Range ++” e Digital Therapy sono disabilitate nella versione pubblica e non generano alcun tipo di output — non è possibile ottenere alcuna predizione, suggerimento, promemoria o altra informazione da esse generata, né reale, né illustrativa, né simulata. Tali funzionalità sono rese disponibili, in forma pienamente operativa, esclusivamente ai partecipanti ammessi a un programma di accesso anticipato (“early access”, v. Sezione 4.3). V. Sezione 3.1 per maggiori dettagli.
Fluent PrevYOU tratta informazioni relative alla salute e supporta la gestione quotidiana del diabete. Prima di utilizzare l'App, leggere per intero i presenti Termini e Condizioni, incluso il Disclaimer Clinico e sulla Digital-Therapy (Sezione 6) e la Limitazione di Responsabilità (Sezione 8). L'App non sostituisce il parere, la diagnosi o il trattamento di un professionista sanitario qualificato, e deve sempre essere utilizzata in affiancamento alle indicazioni di quest'ultimo.
I presenti Termini e Condizioni (i “Termini”) costituiscono un accordo giuridicamente vincolante tra l'utente (“tu”, “tuo/a” o l'“Utente”) e Callea Tech Center LTD, e disciplinano l'accesso e l'utilizzo dell'applicazione mobile Fluent PrevYOU e dei relativi servizi, contenuti e funzionalità.
Scaricando, installando, accedendo, registrandosi o comunque utilizzando l'App, l'Utente conferma di aver letto, compreso e accettato i presenti Termini e la nostra Privacy Policy. In caso di disaccordo anche parziale con i presenti Termini, l'Utente non deve scaricare, accedere o utilizzare l'App.
Se l'App viene utilizzata per conto di un minore o di un'altra persona (v. Sezione 5, “Utilizzo da parte di Genitori e Tutori per Conto di Minori”), l'accettazione dei presenti Termini vale sia in nome proprio, sia, dove applicabile, in nome e per conto di tale persona.
Se l'Utente è un consumatore residente in Italia, nulla nei presenti Termini limita i diritti inderogabili previsti dal Codice del Consumo (D.Lgs. 6 settembre 2005, n. 206) e da altre norme imperative di tutela del consumatore applicabili.
Ai fini dei presenti Termini si applicano le seguenti definizioni:
La versione dell'App attualmente distribuita al pubblico tramite Google Play ha l'unico scopo di mostrare le funzionalità previste dell'App e di permettere agli utenti di familiarizzare con la sua interfaccia, la navigazione e il funzionamento generale.
In questa versione distribuita al pubblico: la funzionalità di predizione glicemica, la funzionalità “In Range ++” e le funzionalità di gestione della Digital Therapy sono disabilitate. Tali funzionalità non elaborano dati biometrici reali e non producono né mostrano alcuna predizione, suggerimento, output, promemoria o altra informazione di alcun tipo. Nessun dato, valore o informazione generata da queste funzionalità può essere ottenuto tramite la versione demo distribuita al pubblico, sia essa reale, illustrativa o simulata. Qualsiasi schermata relativa a queste funzionalità presente nella versione demo ha il solo scopo di mostrare la navigazione e l'interfaccia previste dall'App, non contiene alcun output funzionale, e non deve essere utilizzata per alcuno scopo, incluse decisioni relative al dosaggio di insulina, alla dieta, all'attività fisica o a qualsiasi altro aspetto della gestione del diabete.
Ci riserviamo il diritto di modificare, a nostra discrezione e senza preavviso, quali funzionalità siano dimostrative piuttosto che operative in una determinata versione dell'App distribuita al pubblico, anche nell'ambito di un'introduzione graduale di funzionalità precedentemente riservate ai partecipanti all'early access.
Le funzionalità di predizione glicemica, “In Range ++” e Digital Therapy, pienamente operative, descritte altrove nei presenti Termini e sul nostro sito web, sono rese disponibili esclusivamente alle persone ammesse a un programma di early access (v. Sezione 4.3), secondo eventuali condizioni ulteriori comunicate al momento dell'iscrizione. Se l'Utente non è stato ammesso a un programma di early access, deve presumere che tali funzionalità non siano operative nel proprio caso, indipendentemente da come possano apparire o essere descritte all'interno dell'App o sul nostro sito web.
Fatto salvo quanto sopra, Fluent PrevYOU è progettata per supportare la gestione quotidiana del diabete di Tipo 1 e di Tipo 2 attraverso:
L'App è attualmente resa disponibile gratuitamente su Android tramite Google Play. Ci riserviamo il diritto di modificare, sospendere o interrompere qualsiasi funzionalità del Servizio, in tutto o in parte, in qualsiasi momento, incluse le funzionalità attualmente offerte tramite programmi di early access, fatta salva la Sezione 13 (Modifiche ai Presenti Termini e al Servizio).
Attualmente, la tecnologia di intelligenza artificiale non è utilizzata nel modello di predizione glicemica. Qualora ciò dovesse cambiare in futuro, aggiorneremo i presenti Termini e la documentazione correlata di conseguenza.
L'App è destinata a: (a) adulti (di età pari o superiore a 18 anni) che vivono con il diabete; (b) genitori o tutori legali che gestiscono la cura del diabete di un minore di età compresa tra 0 e 18 anni, come descritto nella Sezione 5; e (c) operatori sanitari e membri di una Rete di Supporto autorizzata che assistono tali persone.
L'App non è destinata a essere utilizzata direttamente e senza supervisione da minori di 18 anni. Qualsiasi utilizzo dell'App da parte o per conto di un minore deve essere avviato, configurato e supervisionato da un genitore o tutore legale conformemente alla Sezione 5.
Per accedere a determinate funzionalità potrebbe essere necessario registrare un Account e fornire informazioni accurate, aggiornate e complete. L'Utente è responsabile della riservatezza delle proprie credenziali di accesso e di ogni attività svolta tramite il proprio Account. Qualsiasi utilizzo non autorizzato dell'Account deve essere segnalato prontamente a support@fluentcommunity.com.
Come indicato nelle Sezioni 3.1 e 3.2, le funzionalità di predizione glicemica, “In Range ++” e gestione della Digital Therapy, pienamente operative (incluso “PrevYOU per Genitori”), sono rese disponibili esclusivamente tramite programmi di early access. La partecipazione a un programma di early access è volontaria, può richiedere la comunicazione di informazioni aggiuntive (ad esempio tipo di diabete e ospedale/clinica di riferimento) e può essere soggetta a condizioni ulteriori comunicate al momento dell'iscrizione. Le funzionalità offerte in early access sono fornite su base sperimentale e “nello stato in cui si trovano” (as available) e possono essere modificate, limitate o revocate in qualsiasi momento.
Fluent PrevYOU è progettata, in parte, per supportare genitori e tutori legali di bambini e adolescenti (0–18 anni) che vivono con il diabete. Quando l'App è utilizzata in relazione a un minore, si applicano le seguenti disposizioni:
Se si viene a conoscenza del fatto che un minore stia utilizzando l'App direttamente e senza adeguata supervisione genitoriale o tutoria, si prega di contattarci immediatamente a support@fluentcommunity.com affinché possiamo adottare le misure opportune.
La presente Sezione si applica sia alla versione demo distribuita al pubblico, sia a qualsiasi versione funzionale dell'App resa disponibile tramite un programma di early access. Come indicato nella Sezione 3.1, le funzionalità di predizione glicemica, “In Range ++” e Digital Therapy non sono operative nella versione attualmente disponibile su Google Play; i disclaimer che seguono diventano direttamente rilevanti nel momento e nella misura in cui tali funzionalità vengano attivate tramite un programma di early access.
Fluent PrevYOU è uno strumento informativo e di supporto all'autogestione. Non intende fornire, e non fornisce, diagnosi medica, parere medico o trattamento, e non sostituisce la consultazione con, o il giudizio professionale di, un Operatore Sanitario qualificato.
Consultare sempre il proprio medico, diabetologo, dietista o altro Operatore Sanitario qualificato (o quello del proprio figlio) prima di modificare il dosaggio di insulina, la terapia farmacologica, la dieta o l'attività fisica, e prima di fare riferimento a qualsiasi predizione, suggerimento, promemoria o informazione fornita dall'App. Non ignorare, ritardare o interrompere mai un parere medico o un trattamento professionale sulla base di informazioni ottenute tramite l'App.
Le funzionalità di predizione glicemica e “In Range ++” generano stime e suggerimenti basati su modelli matematico-statistici, sulle informazioni biometriche fornite dall'Utente e sugli schemi di azione selezionati. Si tratta di stime probabilistiche, non di misurazioni cliniche o garanzie, che possono risultare inesatte, incomplete o non adeguate alla specifica condizione fisiologica dell'Utente in un determinato giorno. Tali funzionalità non sostituiscono la misurazione della glicemia effettuata tramite un glucometro certificato o un sistema di monitoraggio continuo della glicemia (CGM), né alcun altro dispositivo diagnostico.
Le funzionalità di gestione della Digital Therapy consentono a un Utente o al suo Operatore Sanitario di caricare nell'App piani terapeutici, alimentari e di attività fisica, e di ricevere promemoria e avvisi basati su tali piani. Si tratta di strumenti per organizzare e rafforzare l'adesione a un piano terapeutico già prescritto da un Operatore Sanitario. Non esaminiamo, non validiamo e non approviamo l'adeguatezza clinica di alcun piano terapeutico o alimentare inserito nell'App da un Utente, da un genitore/tutore o da un Operatore Sanitario, e non siamo responsabili per errori nel piano così come inserito, né per la sua idoneità clinica.
L'App non deve mai essere utilizzata come strumento per la gestione di emergenze mediche. In caso di sintomi di un episodio grave di ipoglicemia o iperglicemia, chetoacidosi diabetica, perdita di coscienza o qualsiasi altra emergenza medica, contattare immediatamente i servizi di emergenza (ad esempio il 112) o richiedere immediata assistenza medica di persona. Non fare affidamento sull'App, sulle sue predizioni o sulle sue notifiche in una situazione di emergenza.
Salvo quanto espressamente indicato all'interno dell'App o nella documentazione di accompagnamento, Fluent PrevYOU è fornita come strumento generale di supporto al benessere e all'autogestione. Qualsiasi riferimento a studi clinici, partnership accademiche o collaborazioni di ricerca (incluse quelle con l'Università di Verona e l'Università di Padova) descrive la ricerca scientifica alla base dello sviluppo dell'App e non costituisce una dichiarazione che l'App sia stata certificata come dispositivo medico in alcuna giurisdizione, salvo quanto espressamente indicato.
L'App, incluso il suo codice sorgente, gli algoritmi, i modelli di predizione, il design visivo, la grafica, i loghi, i marchi (inclusi “Fluent” e “Fluent PrevYOU”), i testi e ogni altro contenuto e tecnologia sottostante (collettivamente, la “PI”), sono di proprietà di, o concessi in licenza a, Callea Tech Center LTD e sono protetti dalle leggi e dai trattati in materia di diritto d'autore, marchi, banche dati, segreti commerciali e altra proprietà intellettuale.
Nel rispetto dei presenti Termini, concediamo all'Utente una licenza limitata, non esclusiva, non trasferibile e revocabile per scaricare e utilizzare l'App su un dispositivo personale di proprietà o sotto il controllo dell'Utente, esclusivamente per uso personale e non commerciale (o, nel caso di un genitore/tutore, per la cura del/i minore/i di cui è responsabile).
L'Utente non deve: (a) copiare, modificare, decompilare o disassemblare l'App o qualsiasi parte dei suoi modelli o algoritmi sottostanti, salvo nella misura espressamente consentita dalla legge applicabile; (b) noleggiare, cedere in leasing, vendere, concedere in sublicenza, cedere o altrimenti trasferire alcun diritto sull'App; (c) rimuovere, oscurare o alterare eventuali avvisi di proprietà; oppure (d) utilizzare il nome, il logo o i marchi Fluent senza il nostro previo consenso scritto.
Qualsiasi feedback, suggerimento o idea volontariamente inviato in relazione all'App potrà essere utilizzato da noi senza restrizioni e senza alcun compenso per l'Utente.
Nulla nei presenti Termini limita o esclude la nostra responsabilità per morte o lesioni personali causate da nostra negligenza, per dolo o frode, o per qualsiasi altra responsabilità che non può essere limitata o esclusa ai sensi della legge applicabile, incluse le disposizioni imperative del Codice del Consumo italiano a tutela del consumatore.
Fatto salvo quanto precede, e nella misura massima consentita dalla legge applicabile:
L'Utente riconosce che tali limitazioni riflettono una ragionevole allocazione del rischio, tenuto conto del fatto che l'App è offerta gratuitamente come strumento di supporto all'autogestione, e che costituiscono un elemento fondamentale dell'accordo tra l'Utente e noi.
Nella misura massima consentita dalla legge applicabile, l'Utente si impegna a indennizzare e tenere indenne Callea Tech Center LTD, i suoi amministratori, dipendenti, collaboratori e partner accademici da e contro qualsiasi pretesa, responsabilità, danno, perdita e spesa (incluse le spese legali ragionevoli) derivante da o in qualsiasi modo connesso a: (a) una violazione dei presenti Termini da parte dell'Utente; (b) un uso improprio dell'App; (c) qualsiasi informazione o Contenuto inviato dall'Utente (o da un minore di cui è responsabile) tramite l'App; oppure (d) una violazione di qualsiasi legge applicabile o diritto di terzi da parte dell'Utente.
La nostra raccolta e utilizzo di dati personali, inclusi i dati relativi alla salute, è descritta nella nostra Privacy Policy, disponibile su https://www.iubenda.com/privacy-policy/58631363/full-legal (la “Privacy Policy”), che costituisce parte integrante dei presenti Termini. Utilizzando l'App, l'Utente accetta anche i termini della Privacy Policy.
Le informazioni relative alla salute fornite dall'Utente o da un genitore/tutore sono trattate come categoria particolare di dati personali. Adottiamo misure tecniche e organizzative adeguate per proteggere tali dati, in conformità al Regolamento (UE) 2016/679 (GDPR), al Codice in materia di protezione dei dati personali (D.Lgs. 196/2003, come modificato dal D.Lgs. 101/2018) e, per gli utenti residenti nel Regno Unito, all'UK GDPR e al Data Protection Act 2018.
Gli utenti residenti in Italia hanno il diritto di presentare un reclamo al Garante per la Protezione dei Dati Personali (www.garanteprivacy.it), fatti salvi gli altri diritti previsti dal GDPR e dalla normativa italiana applicabile, incluso il diritto di proporre ricorso all'autorità giudiziaria.
È possibile richiedere l'accesso, la rettifica o la cancellazione permanente del proprio account e dei dati associati in qualsiasi momento contattando support@fluentcommunity.com. Previa verifica dell'identità, tali richieste saranno gestite in conformità alla normativa applicabile in materia di protezione dei dati e alla nostra Privacy Policy.
Utilizzando l'App, l'Utente si impegna a non:
Ci riserviamo il diritto di sospendere o terminare l'Account dell'Utente, senza preavviso, qualora riteniamo ragionevolmente che i presenti Termini o la legge applicabile siano stati violati.
L'App può integrarsi con, o fornire collegamenti a, servizi di terze parti, inclusi Google Play, fornitori di posta elettronica utilizzati per le notifiche alla Rete di Supporto, piattaforme di ricerca accademica e processori di pagamento di terze parti utilizzati per donazioni volontarie. Non controlliamo, e non siamo responsabili per, il contenuto, l'accuratezza, la disponibilità o le pratiche in materia di privacy di tali servizi di terze parti. L'utilizzo di qualsiasi servizio di terze parti è disciplinato dai termini e dalla privacy policy propri di tale terza parte.
Potremo aggiornare o modificare periodicamente i presenti Termini per riflettere cambiamenti del Servizio, requisiti legali o regolamentari, o le nostre prassi commerciali, inclusa l'evoluzione dell'App dalle funzionalità di early access verso la disponibilità generale.
In caso di modifiche sostanziali, ci impegneremo a fornire un preavviso ragionevole, ad esempio tramite una notifica in-app, un avviso sul nostro sito web (www.fluentcommunity.com) o un'e-mail all'indirizzo associato all'Account dell'Utente. La data “Ultimo aggiornamento” indicata all'inizio dei presenti Termini indica quando questi sono stati revisionati per l'ultima volta.
L'utilizzo continuato dell'App successivamente alla data di efficacia di Termini modificati costituisce accettazione di tali modifiche. In caso di disaccordo con i Termini modificati, l'Utente deve cessare di utilizzare l'App e può richiedere la cancellazione del proprio Account conformemente alla Sezione 10.
Ci riserviamo inoltre il diritto di modificare, sospendere o interrompere l'App, o qualsiasi sua funzionalità (incluse le funzionalità di early access), in qualsiasi momento e senza responsabilità nei confronti dell'Utente, fatta salva la legge applicabile.
I presenti Termini restano in vigore per tutta la durata dell'utilizzo dell'App da parte dell'Utente. L'Utente può cessare di utilizzare l'App, e richiedere la cancellazione del proprio Account e dei dati associati, in qualsiasi momento contattando support@fluentcommunity.com.
Potremo sospendere o terminare l'accesso dell'Utente all'App, in tutto o in parte, in qualsiasi momento, con o senza motivo o preavviso, incluso qualora riteniamo ragionevolmente che l'Utente abbia violato i presenti Termini, si sia impegnato in attività fraudolente o illegali, o laddove la continuazione della fornitura del Servizio comporti un rischio legale o di sicurezza per noi o per altri.
Le Sezioni 6 (Disclaimer Clinico e sulla Digital-Therapy), 7 (Proprietà Intellettuale), 8 (Limitazione di Responsabilità), 9 (Indennizzo) e 15 (Legge Applicabile e Foro Competente), insieme a qualsiasi altra disposizione che per sua natura debba sopravvivere, resteranno in vigore anche dopo la cessazione dei presenti Termini.
I presenti Termini, e qualsiasi controversia o pretesa derivante da o connessa ad essi o al loro oggetto, formazione o validità (incluse controversie o pretese extracontrattuali), sono disciplinati e interpretati in conformità alle leggi dell'Inghilterra e del Galles, senza riguardo ai principi di conflitto di leggi.
I tribunali dell'Inghilterra e del Galles hanno giurisdizione esclusiva per dirimere qualsiasi controversia o pretesa derivante da o connessa ai presenti Termini.
Disposizione specifica per i consumatori residenti in Italia: qualora l'Utente sia un consumatore ai sensi del Codice del Consumo (D.Lgs. 206/2005) e risieda in Italia, quanto precede non priva l'Utente della protezione garantita dalle disposizioni imperative della legge del proprio Stato di residenza applicabili in virtù dell'art. 6 del Regolamento (CE) n. 593/2008 (“Roma I”) e dell'art. 18 del Regolamento (UE) n. 1215/2012 (“Bruxelles I bis”). In particolare, tale Utente ha il diritto di proporre azione dinanzi al giudice del luogo in cui è domiciliato, in alternativa ai giudici dell'Inghilterra e del Galles, e conserva la protezione delle norme imperative italiane ed europee a tutela del consumatore, incluso il Codice del Consumo, indipendentemente dalla legge scelta come legge regolatrice del presente contratto.
Risoluzione delle controversie online (ODR): gli Utenti consumatori residenti nell'Unione Europea possono inoltre presentare un reclamo tramite la piattaforma europea di risoluzione delle controversie online (ODR), accessibile all'indirizzo https://ec.europa.eu/consumers/odr, senza pregiudizio per il diritto di adire l'autorità giudiziaria competente.
I presenti Termini, insieme alla Privacy Policy e alla Cookie Policy, costituiscono l'accordo completo tra l'Utente e Callea Tech Center LTD in relazione all'App e sostituiscono qualsiasi accordo o intesa precedente, scritta o orale.
Qualora una disposizione dei presenti Termini sia ritenuta invalida, illegale o inapplicabile da un'autorità giudiziaria competente, tale disposizione si considererà modificata nella misura minima necessaria per renderla valida ed efficace, e le restanti disposizioni continueranno a produrre pieni effetti.
La mancata applicazione di un diritto o di una disposizione dei presenti Termini da parte nostra non costituisce rinuncia a tale diritto o disposizione.
L'Utente non può cedere o trasferire i presenti Termini, o alcun diritto od obbligo derivante da essi, senza il nostro previo consenso scritto. Possiamo cedere i presenti Termini, in tutto o in parte, senza restrizioni, incluso nell'ambito di una fusione, acquisizione o cessione di attività.
Non saremo responsabili per alcuna mancata o ritardata prestazione derivante da causali fuori dal nostro ragionevole controllo, inclusi eventi di forza maggiore, calamità naturali, guerra, terrorismo, controversie sindacali, guasti a internet o alle telecomunicazioni, o provvedimenti governativi.
I presenti Termini sono resi disponibili anche in lingua inglese. In caso di conflitto tra la versione italiana e quella inglese, prevale la versione inglese, salvo quanto diversamente previsto da norme imperative italiane o europee a tutela del consumatore, nel qual caso prevarrà l'interpretazione più favorevole al consumatore conforme a tali norme.
Società: Callea Tech Center LTD
Sede legale: 61 Earls Ct Square, Londra SW5 9DG, Regno Unito
Per qualsiasi domanda relativa ai presenti Termini, è possibile contattarci:
Fluent PrevYOU's solutions cater to both Type 1 and Type 2 diabetes — ensuring comprehensive support for varying needs and conditions.
If you have been diagnosed with diabetes recently you can find some useful information here. We also invite you to check other sources such as National Diabetes Associations websites. We view education as the most powerful tool for effectively managing and overcoming diabetes challenges.
| Feature | Type 1 Diabetes | Type 2 Diabetes |
|---|---|---|
| Cause | Autoimmune: immune system attacks insulin-producing cells in the pancreas. | Insulin resistance; body doesn't use insulin properly; may later produce less insulin. |
| Onset | Usually develops in childhood or adolescence, but can occur at any age. | Typically develops in adults over 45, but increasingly seen in younger people. |
| Insulin Production | Little to no insulin produced. | Insulin produced, but not used effectively. |
| Treatment | Requires daily insulin therapy. | Managed with lifestyle changes, oral medications, sometimes insulin. |
| Symptoms | Develop quickly and are more noticeable. | Develop gradually, may go unnoticed for years. |
| Risk Factors | Genetic predisposition; not linked to lifestyle. | Family history, obesity, sedentary lifestyle, age, ethnicity. |
| Prevention | Cannot be prevented. | Often preventable through healthy lifestyle choices. |
| Prevalence | About 5–10% of diabetes cases. | About 90–95% of diabetes cases. |
Type 1 Diabetes (T1D) is a chronic autoimmune condition in which the body's immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body produces little to no insulin.
Onset: Typically develops in children, adolescents, or young adults, though it can occur at any age. The onset is usually rapid and requires immediate medical attention.
Diagnosis: Fasting blood glucose, HbA1c levels, autoantibodies (GAD, IA-2), C-peptide levels.
Treatment:
Complications (if unmanaged): Diabetic ketoacidosis (DKA); long-term: cardiovascular disease, neuropathy, nephropathy, retinopathy.
Management Goals: Maintain blood glucose within target range, prevent acute and chronic complications, improve quality of life.
A chronic condition that occurs when the body either doesn't produce enough insulin or becomes resistant to insulin, preventing glucose from entering cells efficiently. It is the most common form of diabetes, accounting for 90–95% of cases.
Causes: Insulin resistance, genetics, poor diet, physical inactivity, obesity, ethnicity (higher risk in African American, Hispanic/Latino, Native American, Asian American populations).
Management: Healthy eating, regular physical activity, weight loss, blood sugar monitoring, medications or insulin therapy as needed.
A type of diabetes that develops during pregnancy — typically between the 24th and 28th week — due to hormonal changes causing insulin resistance. Affects 5–10% of pregnancies in the U.S.
Risks for baby: High birth weight, premature birth, low blood sugar after birth, increased risk of obesity and type 2 diabetes later.
Risks for mother: Preeclampsia, cesarean delivery, future type 2 diabetes.
Management: Healthy diet and regular physical activity, monitoring blood sugar levels, insulin therapy if needed.
Breakthrough innovation: personalised blood glucose prediction and the In Range ++ feature.
At the heart of the breakthrough introduced by Fluent research lies the personalised blood glucose prediction feature implemented in Fluent PrevYOU. This cutting-edge innovation is set to revolutionize diabetes management by delivering individualized forecasts that empower users to maintain optimal glucose levels with greater precision.
Our engineers with a motorsport background developed the blood glucose prediction model using the same exact approach used in Formula 1 to predict lap times of racing cars.
The model runs on a smartphone, delivering real-time predictions with immediacy required for effective daily use.
The prediction model evolves with you and with the natural changes that occur in your body over time.
This approach focuses on extending the time during which blood glucose levels remain within the target range, thereby reducing complications associated with diabetes.
We're dedicating increasing effort to developing this feature because we truly believe it has the potential to elevate your diabetes management — making it both simpler and more effective.
Together, we can transform the vision of
"Zero Time Out of Range"
into a reality.
PrevYOU Digital Therapy — seamlessly integrating continuous personalised therapy into patients' daily lives.
Current therapy prescription methods lack real-time integration with patients' lifestyles, leading to suboptimal adherence and effectiveness. People often struggle with managing their diabetes due to the absence of continuous, personalised guidance and prompts that align with their daily routines.
Research indicates that patients who do not receive continuous therapy prompts are more likely to experience poor adherence, leading to ineffective treatment outcomes. Better therapy integration into patients' daily lives can significantly improve adherence and effectiveness.
Continuous therapy integration and delivery can enable unprecedented harmonization of medical treatment and diet with patient's lifestyle. The switch to digital therapy ensures that therapy is not only prescribed but also seamlessly integrated into daily routines.
Parents of children and teens with diabetes face unique challenges helping them maintain optimal blood glucose levels, which can impact daily activities and long-term health. Current solutions often lack personalization and adaptability, leading to suboptimal management.
Parents coordinating care for their children can lighten and simplify the work of the extended Caregiver Team — represented for example by teachers and sport coaches. These figures can greatly benefit from the real-time prompts provided by the digital therapy implementation into Fluent PrevYOU to get guidance on how to help young people better manage their condition in the school or sports context.
Currently under development. Empowers parents of children and teens aged 0–18 with Type 1 diabetes, along with their caregivers, to manage an effective and personalised diabetes care plan.
Adults living with diabetes can keep their prescribed medical treatment and diet fully aligned with everyday life, so following the plan agreed with their care team becomes second nature rather than an extra task.
The continuous therapy integration and delivery features of Fluent PrevYOU offers doctors and healthcare providers the possibility to enable unprecedented harmonization of medical treatment and diet with patient's lifestyle.
Our committed areas of R&D for the next phase of Fluent PrevYOU development.
Although Fluent research has already delivered breakthroughs which are now making possible to reach the "Zero Time Out of Range" condition, we are fully committed to further improving the effectiveness of our solution for diabetes management.
Below is a summary of the research and development areas we will be focusing on in the near future.
Further development and validation of the mathematical model for personalised blood glucose prediction — enabled by the increasing volume of user data from real-world life conditions.
Further development of Fluent PrevYOU "In Range ++" feature which suggests patterns of actions offering longer time in range potential.
Improvements to Fluent PrevYOU continuous therapy integration and delivery features to enhance therapy adherence and effectiveness.
Improvements to the workflow currently available to doctors and dieticians for digital therapy implementation and upload into Fluent PrevYOU.
Ongoing and future developments include a version of the app designed for parents of children and teens aged 0–18 to manage their care — from action plans based on blood glucose predictions to supporting their child in person or remotely.
Join our early access programs to be among the first to experience and help shape the next generation of Fluent PrevYOU — tailored for parents, adults, and healthcare providers.
Fluent researchers are currently working on a tailored solution of PrevYOU for parents. Using its blood glucose prediction, the app helps parents anticipate highs and lows before they happen and define a targeted action plan to keep their child's glucose in the optimal range. Parents can then support them through it wherever they are — in person, or remotely at school for example, by looping in teachers when they can't be there themselves.
Fluent researchers are currently expanding early access to digital therapy and personalised blood glucose prediction for adults living with diabetes, ahead of their wider rollout.
Join the early access program, and you're not just testing features for yourself — you're helping build a healthier, easier life for parents and kids managing diabetes too.
The digital therapy features of Fluent PrevYOU offer doctors and healthcare providers the possibility to enable unprecedented harmonization of medical treatment and diet with patient's lifestyle.
If you are a doctor or caregiver interested in the possibilities offered by Fluent PrevYOU such as digital therapy implementation, contact us directly by email to join the program.
Provide the information requested below and submit your application — we'll get back to you as soon as possible!
Fluent PrevYOU empowers parents to define an action plan for their child and then be there for them — whether they're together at home, or apart during school hours.
Every action plan starts with the parent, who defines it inside Fluent PrevYOU based on the child's blood glucose prediction. From there, the app puts parents in control of how they support their kid through it — in person, or remotely at school for example, when they can't be there themselves.
A long-standing academic partnership at the heart of Fluent's clinical research.
From the very first steps of the Fluent project, the collaboration with Prof. Enzo Bonora and his multidisciplinary equipe at the University Hospital of Verona (AOUI Verona) has been central to the scientific credibility and clinical grounding of everything we have built.
Prof. Bonora is a world-renowned endocrinologist and diabetologist, internationally recognised as one of the foremost authorities in diabetes and metabolic disease research. His career spans decades of landmark contributions — from epidemiological studies on the prevalence of insulin resistance and Type 2 diabetes in Europe, to seminal work on cardiovascular risk in people with diabetes. He has served in leadership roles at major international diabetes organisations and his work has been cited thousands of times in the global scientific literature.
Partnering with Prof. Bonora's equipe from day one has meant that the Fluent project has been shaped not only by engineering and data science excellence, but by deep, evidence-based clinical expertise. This foundation has been essential in ensuring that Fluent PrevYOU delivers a solution that is not only technologically innovative, but medically sound and grounded in real-world patient care.
Watch Prof. Enzo Bonora discuss the evolving landscape of diabetes management, the importance of personalised approaches, and the role of technology in empowering patients.
To evaluate the acceptance, usability, and practical integration of the Fluent App into the daily self-management routines of people living with diabetes, under clinical supervision at the University Hospital of Verona.
The trial involved individuals with Type 1 diabetes recruited through the Endocrinology and Diabetes Unit of AOUI Verona, representing a diverse range of age groups, diabetes duration, and management profiles.
Participants were introduced to the Fluent App and followed over an evaluation period. Data on app usage, glucose management patterns, and user feedback were systematically collected and analysed by the clinical team.
The report documents strong acceptance of the app among participants, with positive feedback on its usability and perceived utility for daily diabetes management. The Clinical Team validated the app's potential for broader adoption in personalised diabetes care and recommended moving to a larger clinical trial to assess its impact on clinical outcomes.
Academic partnership and research collaboration.
We are proud to collaborate with Prof. Bruno Scarpa, Professor of Statistics at the Department of Statistical Sciences of the University of Padova — one of the oldest and most prestigious universities in the world, founded in 1222.
Prof. Scarpa's research sits at the frontier of modern statistical science, spanning Bayesian inference, nonparametric and semiparametric modelling, machine learning, functional data analysis, and statistical methods for biomedical and health data. His work is distinguished by the rigorous integration of cutting-edge statistical theory with high-impact real-world applications, including complex longitudinal health datasets of the kind generated by continuous glucose monitoring devices.
This partnership brings to the Fluent project a level of statistical depth and methodological rigour that is essential for translating raw data into clinically meaningful, personalised insights — and for pushing the boundaries of what predictive modelling can achieve in diabetes care.
Development and application of Bayesian models and probabilistic machine learning methods for inference under uncertainty — directly applicable to personalised glucose prediction.
Statistical methods for data observed as curves or functions over time — ideal for analysing the rich time-series profiles produced by continuous glucose monitors (CGM).
Applied statistical modelling for health and life-science datasets, bridging the gap between theoretical methodology and actionable clinical knowledge.
Design and evaluation of predictive algorithms — including deep learning architectures — for complex, high-dimensional biomedical time-series data.
PrevYOU support, early access programs, and educational program enquiries.
Technical support and questions about the Fluent PrevYOU mobile app.
support@fluentcommunity.comApply to join early access programs for parents, adults, or healthcare providers.
info@fluentcommunity.comEnquiries about Fluent's educational programs in schools and institutions.
education@fluentcommunity.comTechnical support, frequently asked questions, and account help for the Fluent PrevYOU mobile app.
If you're experiencing technical issues, have questions about how Fluent PrevYOU works, or need help with your account, our support team is ready to assist.
Partnerships with schools and institutions to support diabetes education globally.
Fluent's educational programs in collaboration with schools and institutions are being finalized. Contact us for early enquiries.
A transformative approach to medical research — and a compelling platform for the future of precision medicine.
Fluent PrevYOU mobile health platform provides access to longitudinal patient data collected under real-world conditions, encompassing diverse age groups, genders, and biometric profiles — offering a uniquely rich dataset for translational and clinical research applications.
Ongoing exploration and validation of AI-driven predictive models using real-world data to further advance precision medicine.
Research into digital twin technology for personalised diabetes simulation and treatment optimization.
Exploring integration with next-generation wearable biosensor technology for richer real-time data.
Building systems for seamless real-time data integration across devices, clinicians, and care teams.
If interested in learning more about the strategic research areas for diabetes and other diseases that are currently shaping our innovation pipeline, please contact us.
The Fluent PrevYOU mobile-health app is completely free — because we believe everyone should have access to the most advanced tools for managing diabetes. We've removed financial barriers so anyone can join the journey toward "Zero Time Out of Range."
If Fluent PrevYOU is helping you or someone you care about, consider supporting our mission. Your donation helps keep the app free, expand access to those who need it most, and continue developing life-changing features.
Every contribution — big or small — makes a real difference.